Unveiling 21 Analyst Insights On Boston Scientific
Portfolio Pulse from Benzinga Insights
21 analysts have provided ratings on Boston Scientific (NYSE:BSX) over the last three months, with a majority being bullish. The average 12-month price target is $82.81, reflecting a 10.93% increase from the previous target. Analysts have raised their ratings and price targets, indicating positive sentiment towards the company.
June 18, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Boston Scientific has received predominantly bullish ratings from 21 analysts over the past three months. The average 12-month price target has increased to $82.81, indicating positive sentiment and potential for stock price appreciation.
The majority of analysts have given bullish ratings, and the average price target has increased significantly. This indicates strong positive sentiment and suggests that the stock price is likely to rise in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100